Advent Pharma Ltd. (DSE:ADVENT)

Advent Pharma Statistics

Total Valuation

Advent Pharma has a market cap or net worth of BDT 1.23 billion. The enterprise value is 1.30 billion.

Market Cap	1.23B
Enterprise Value	1.30B

Important Dates

The next estimated earnings date is Thursday, January 29, 2026.

Earnings Date	Jan 29, 2026
Ex-Dividend Date	Nov 23, 2025

Share Statistics

Advent Pharma has 93.13 million shares outstanding. The number of shares has decreased by -0.79% in one year.

Current Share Class	93.13M
Shares Outstanding	93.13M
Shares Change (YoY)	-0.79%
Shares Change (QoQ)	-3.26%
Owned by Insiders (%)	n/a
Owned by Institutions (%)	n/a
Float	n/a

Valuation Ratios

The trailing PE ratio is 18.62.

PE Ratio	18.62
Forward PE	n/a
PS Ratio	2.37
PB Ratio	0.80
P/TBV Ratio	0.80
P/FCF Ratio	74.49
P/OCF Ratio	11.17
PEG Ratio	n/a

Enterprise Valuation

The stock's EV/EBITDA ratio is 8.32, with an EV/FCF ratio of 78.95.

EV / Earnings	19.89
EV / Sales	2.52
EV / EBITDA	8.32
EV / EBIT	13.86
EV / FCF	78.95

Financial Position

The company has a current ratio of 1.60, with a Debt / Equity ratio of 0.05.

Current Ratio	1.60
Quick Ratio	1.09
Debt / Equity	0.05
Debt / EBITDA	0.48
Debt / FCF	4.59
Interest Coverage	10.06

Financial Efficiency

Return on equity (ROE) is 4.33% and return on invested capital (ROIC) is 4.52%.

Return on Equity (ROE)	4.33%
Return on Assets (ROA)	3.07%
Return on Invested Capital (ROIC)	4.52%
Return on Capital Employed (ROCE)	5.34%
Revenue Per Employee	1.63M
Profits Per Employee	206,625
Employee Count	317
Asset Turnover	0.27
Inventory Turnover	5.02

Taxes

In the past 12 months, Advent Pharma has paid 19.02 million in taxes.

Income Tax	19.02M
Effective Tax Rate	22.50%

Stock Price Statistics

The stock price has decreased by -20.61% in the last 52 weeks. The beta is 0.37, so Advent Pharma's price volatility has been lower than the market average.

Beta (5Y)	0.37
52-Week Price Change	-20.61%
50-Day Moving Average	13.30
200-Day Moving Average	14.44
Relative Strength Index (RSI)	48.91
Average Volume (20 Days)	107,284

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, Advent Pharma had revenue of BDT 517.69 million and earned 65.50 million in profits. Earnings per share was 0.71.

Revenue	517.69M
Gross Profit	177.10M
Operating Income	93.99M
Pretax Income	84.52M
Net Income	65.50M
EBITDA	155.97M
EBIT	93.99M
Earnings Per Share (EPS)	0.71

Balance Sheet

The company has 2.17 million in cash and 75.79 million in debt, with a net cash position of -73.63 million or -0.79 per share.

Cash & Cash Equivalents	2.17M
Total Debt	75.79M
Net Cash	-73.63M
Net Cash Per Share	-0.79
Equity (Book Value)	1.54B
Book Value Per Share	17.14
Working Capital	115.27M

Cash Flow

In the last 12 months, operating cash flow was 110.04 million and capital expenditures -93.54 million, giving a free cash flow of 16.50 million.

Operating Cash Flow	110.04M
Capital Expenditures	-93.54M
Free Cash Flow	16.50M
FCF Per Share	0.18

Margins

Gross margin is 34.21%, with operating and profit margins of 18.16% and 12.65%.

Gross Margin	34.21%
Operating Margin	18.16%
Pretax Margin	16.33%
Profit Margin	12.65%
EBITDA Margin	30.13%
EBIT Margin	18.16%
FCF Margin	3.19%

Dividends & Yields

This stock pays an annual dividend of 0.05, which amounts to a dividend yield of 0.38%.

Dividend Per Share	0.05
Dividend Yield	0.38%
Dividend Growth (YoY)	-50.00%
Years of Dividend Growth	n/a
Payout Ratio	21.61%
Buyback Yield	0.79%
Shareholder Yield	1.17%
Earnings Yield	5.33%
FCF Yield	1.34%

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value
Lynch Upside
Graham Number
Graham Upside

Stock Splits

The last stock split was on February 28, 2022. It was a forward split with a ratio of 1.02.

Last Split Date	Feb 28, 2022
Split Type	Forward
Split Ratio	1.02

Scores

Altman Z-Score	n/a
Piotroski F-Score	5